JNJ

224.63

-0.64%↓

UNH

368.32

+0.59%↑

TMO

474.21

+2.06%↑

ISRG

449.84

-0.96%↓

DHR

175.37

+0.49%↑

JNJ

224.63

-0.64%↓

UNH

368.32

+0.59%↑

TMO

474.21

+2.06%↑

ISRG

449.84

-0.96%↓

DHR

175.37

+0.49%↑

JNJ

224.63

-0.64%↓

UNH

368.32

+0.59%↑

TMO

474.21

+2.06%↑

ISRG

449.84

-0.96%↓

DHR

175.37

+0.49%↑

JNJ

224.63

-0.64%↓

UNH

368.32

+0.59%↑

TMO

474.21

+2.06%↑

ISRG

449.84

-0.96%↓

DHR

175.37

+0.49%↑

JNJ

224.63

-0.64%↓

UNH

368.32

+0.59%↑

TMO

474.21

+2.06%↑

ISRG

449.84

-0.96%↓

DHR

175.37

+0.49%↑

Strona główna・Stock List・Abbott Laboratories
Search

Abbott Laboratories

Open

SectorHealthcare

87.13 -0.42

Strong Buy

Price update 6 maj 2026, 15:10 UTC

BuySell

Overview

Share price change

24h

Current

Min

86.31

Max

87.81

Key metrics

By Trading Economics

Income

132M

1.8B

Sales

-295M

11B

P/E

Sector Avg

25.994

67.147

EPS

1.15

Dividend yield

2.68

Profit margin

15.499

Employees

122,000

EBITDA

-980M

1.8B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+37.35% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.68%

2.36%

Next Earnings

16 lip 2026

Next Dividend date

15 maj 2026

Next Ex Dividend date

14 lip 2026

Market Stats

By TradingEconomics

Market Cap

-14B

161B

Previous open

87.55

Previous close

87.13

News Sentiment

By Acuity

24%

76%

85 / 347 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

132.82 / 134.43 Support & Resistance

Abbott Laboratories Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 kwi 2026, 15:13 UTC

Earnings
Major Market Movers

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

DJ

Read

16 kwi 2026, 12:23 UTC

Earnings
Major Market Movers

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

DJ

Read

22 sty 2026, 18:36 UTC

Earnings
Major Market Movers

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

DJ

Read

22 sty 2026, 13:23 UTC

Earnings
Major Market Movers

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

DJ

Read

16 kwi 2026, 20:23 UTC

Earnings

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

DJ

Read

16 kwi 2026, 16:15 UTC

Earnings

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

DJ

Read

16 kwi 2026, 14:00 UTC

Market Talk
Earnings

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

DJ

Read

16 kwi 2026, 13:59 UTC

Market Talk
Earnings

Abbott Laboratories Has Disappointing Quarter -- Market Talk

DJ

Read

16 kwi 2026, 12:05 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

DJ

Read

16 kwi 2026, 11:32 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Sales $11.16B >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Net $1.08B >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs 1Q Adj EPS $1.15 >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

DJ

Read

16 kwi 2026, 11:30 UTC

Earnings
Acquisitions, Mergers, Takeovers

Abbott Labs 1Q EPS 61c >ABT

DJ

Read

11 kwi 2026, 00:00 UTC

Earnings
Acquisitions, Mergers, Takeovers

Big Yachts, Big Bucks -- Barrons.com

DJ

Read

23 mar 2026, 12:50 UTC

Acquisitions, Mergers, Takeovers

Abbott Completes Acquisition Of Exact Sciences >ABT

DJ

Read

20 mar 2026, 13:01 UTC

Acquisitions, Mergers, Takeovers

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

DJ

Read

20 mar 2026, 13:00 UTC

Acquisitions, Mergers, Takeovers

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

DJ

Read

28 sty 2026, 14:48 UTC

Earnings

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

DJ

Read

23 sty 2026, 16:59 UTC

Earnings

Correction to Abbott Stock Drops Article on Jan. 22

DJ

Read

22 sty 2026, 20:42 UTC

Earnings

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

DJ

Read

22 sty 2026, 16:19 UTC

Earnings

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

DJ

Read

22 sty 2026, 15:22 UTC

Earnings

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

DJ

Read

22 sty 2026, 14:41 UTC

Hot Stocks

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

DJ

Read

22 sty 2026, 14:08 UTC

Market Talk
Earnings

Abbott Posts Disappointing 4Q -- Market Talk

DJ

Read

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

37.35% upside

12 Months Forecast

Average 120.24 USD  37.35%

High 143 USD

Low 92 USD

Based on 20 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

16

Buy

4

Hold

0

Sell

Based on 20 analysts giving stock ratings to Abbott Laboratories - Dist in the past 3 months.

Technical Score

By Trading Central

132.82 / 134.43Support & Resistance

Short Term

Weak Bullish Evidence

Bullish events outweigh bearish events.

Intermediate Term

Neutral Evidence

The bullish and bearish events are balanced.

Long Term

Bullish Evidence

All events are bullish.

Sentiment

By Acuity

85 / 347 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Other stocks from the sector

JNJ

Johnson and Johnson

224.63

↓-0.64%

UNH

UnitedHealth Group Inc

368.32

↑ +0.59%

TMO

Thermo Fisher Scientific Inc

474.21

↑ +2.06%

ISRG

Intuitive Surgical Inc

449.84

↓-0.96%

DHR

Danaher Corp

175.37

↑ +0.49%
help-icon Live chat